cplbio.com
Skip to content
Home
Home
About Us
Joint Venture Partners
Board of Directors
Management Team
R & D
R&D Pipeline
Manufacturing
Technology
Recombinant Nanoparticle Technology
Virus Like Particle
Products
Quality
Media Center
News & Events
Press Releases
Resource
Contact
CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza
Date:
25-11-2016
Details:
Previous Post
Top